124 related articles for article (PubMed ID: 24815480)
1. Serum vascular endothelial growth factor-A (VEGF-A) as a biomarker in squamous cell carcinoma of head and neck patients undergoing chemoradiotherapy.
Srivastava VK; Gara RK; Rastogi N; Mishra DP; Ahmed MK; Gupta S; Goel MM; Bhatt ML
Asian Pac J Cancer Prev; 2014; 15(7):3261-5. PubMed ID: 24815480
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy.
Dietz A; Rudat V; Conradt C; Weidauer H; Ho A; Moehler T
Head Neck; 2000 Oct; 22(7):666-73. PubMed ID: 11002321
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck.
Gokhale AS; Haddad RI; Cavacini LA; Wirth L; Weeks L; Hallar M; Faucher J; Posner MR
Oral Oncol; 2005 Jan; 41(1):70-6. PubMed ID: 15598588
[TBL] [Abstract][Full Text] [Related]
4. The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Hsiao CC; Huang CC; Shih LH; Chen SW; Li SH
BMC Cancer; 2018 Aug; 18(1):837. PubMed ID: 30126380
[TBL] [Abstract][Full Text] [Related]
5. Influence of serum VEGF levels on therapeutic outcome and diagnosis/prognostic value in patients with cervical cancer.
Du K; Gong HY; Gong ZM
Asian Pac J Cancer Prev; 2014; 15(20):8793-6. PubMed ID: 25374209
[TBL] [Abstract][Full Text] [Related]
6. [Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases].
Wang XS; Liu MZ; Zhang CQ; Cai L; Cui NJ
Ai Zheng; 2006 Nov; 25(11):1428-32. PubMed ID: 17094915
[TBL] [Abstract][Full Text] [Related]
7. Serum vascular endothelial growth factor as a predictive factor in metronomic (weekly) Paclitaxel treatment for advanced head and neck cancer.
Caballero M; Grau JJ; Blanch JL; Domingo-Domenech J; Auge JM; Jimenez W; Bernal-Sprekelsen M
Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1143-8. PubMed ID: 18025320
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
9. Baseline caspase activity predicts progression free survival of temsirolimus-treated head neck cancer patients.
John K; Rösner I; Keilholz U; Gauler T; Bantel H; Grünwald V
Eur J Cancer; 2015 Aug; 51(12):1596-602. PubMed ID: 26048456
[TBL] [Abstract][Full Text] [Related]
10. [Effect of the levels of vascular endothelial growth factor-A and C on the prognosis of patients with laryngeal carcinoma].
Düzen B; Taş A; Demir M; Usta U; Yağız R; Koten M; Karasalihoğlu A
Kulak Burun Bogaz Ihtis Derg; 2011; 21(3):122-8. PubMed ID: 21595615
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive value of serum vascular endothelial growth factor (VEGF) in squamous cell carcinoma of the head and neck.
Khademi B; Soleimanpour M; Ghaderi A; Mohammadianpanah M
Oral Maxillofac Surg; 2014 Jun; 18(2):187-96. PubMed ID: 23456015
[TBL] [Abstract][Full Text] [Related]
12. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.
Lowe NM; Bernstein JM; Mais K; Garcez K; Lee LW; Sykes A; Thomson DJ; Homer JJ; West CM; Slevin NJ
J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of vascular endothelial growth factor during and after radiotherapy in combination with celecoxib in patients with advanced head and neck cancer.
Halamka M; Cvek J; Kubes J; Zavadova E; Kominek P; Horacek J; Dusek L; Feltl D
Oral Oncol; 2011 Aug; 47(8):763-7. PubMed ID: 21696999
[TBL] [Abstract][Full Text] [Related]
14. Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck.
Gehrmann M; Specht HM; Bayer C; Brandstetter M; Chizzali B; Duma M; Breuninger S; Hube K; Lehnerer S; van Phi V; Sage E; Schmid TE; Sedelmayr M; Schilling D; Sievert W; Stangl S; Multhoff G
Radiat Oncol; 2014 Jun; 9():131. PubMed ID: 24912482
[TBL] [Abstract][Full Text] [Related]
15. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
16. High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy.
Cheng JC; Graber MS; Hsu FM; Tsai CL; Castaneda L; Lee JM; Chang DT; Koong AC
Ann Surg Oncol; 2014 Jul; 21(7):2361-8. PubMed ID: 24623035
[TBL] [Abstract][Full Text] [Related]
17. Pathologic response during chemo-radiotherapy and variation of serum VEGF levels could predict effects of chemo-radiotherapy in patients with esophageal cancer.
Yu JP; Lu WB; Wang JL; Ni XC; Wang J; Sun ZQ; Sun SP
Asian Pac J Cancer Prev; 2015; 16(3):1111-6. PubMed ID: 25735340
[TBL] [Abstract][Full Text] [Related]
18. Follow-up with serum Cyfra 21-1 in patients with squamous cell carcinomas of the head and neck.
Kuropkat C; Lippert BM; Werner JA
Oncology; 2002; 63(3):280-5. PubMed ID: 12381908
[TBL] [Abstract][Full Text] [Related]
19. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Microparticles and Vascular Endothelial Growth Factor in Patients With Head and Neck Cancer Undergoing Radiotherapy or Radiochemotherapy.
Sierko E; Sobierska M; Zabrocka E; Kruszewska J; Myśliwiec M; Lipska A; Radziwon P; Wojtukiewicz MZ
In Vivo; 2019; 33(2):581-586. PubMed ID: 30804145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]